These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34813500)

  • 1. Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions.
    Wang X; Allen M; İş Ö; Reddy JS; Tutor-New FQ; Castanedes Casey M; Carrasquillo MM; Oatman SR; Min Y; Asmann YW; Funk C; Nguyen T; Ho CC; Malphrus KG; Seyfried NT; Levey AI; Younkin SG; Murray ME; Dickson DW; Price ND; Golde TE; Ertekin-Taner N
    J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34813500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Allen M; Wang X; Burgess JD; Watzlawik J; Serie DJ; Younkin CS; Nguyen T; Malphrus KG; Lincoln S; Carrasquillo MM; Ho C; Chakrabarty P; Strickland S; Murray ME; Swarup V; Geschwind DH; Seyfried NT; Dammer EB; Lah JJ; Levey AI; Golde TE; Funk C; Li H; Price ND; Petersen RC; Graff-Radford NR; Younkin SG; Dickson DW; Crook JR; Asmann YW; Ertekin-Taner N
    Alzheimers Dement; 2018 Mar; 14(3):352-366. PubMed ID: 29107053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.
    Iohan LDCC; Lambert JC; Costa MR
    PLoS One; 2022; 17(4):e0266405. PubMed ID: 35421130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
    Stutzbach LD; Xie SX; Naj AC; Albin R; Gilman S; ; Lee VM; Trojanowski JQ; Devlin B; Schellenberg GD
    Acta Neuropathol Commun; 2013 Jul; 1():31. PubMed ID: 24252572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data.
    Patel H; Dobson RJB; Newhouse SJ
    J Alzheimers Dis; 2019; 68(4):1635-1656. PubMed ID: 30909231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
    Zhang Y; Xue Y; Wang L; Han Z; Wang T; Zhang H; Liu G; Xiao X
    J Alzheimers Dis; 2023; 96(1):57-64. PubMed ID: 37742642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.
    Huin V; Deramecourt V; Caparros-Lefebvre D; Maurage CA; Duyckaerts C; Kovari E; Pasquier F; Buée-Scherrer V; Labreuche J; Behal H; Buée L; Dhaenens CM; Sablonnière B
    Mov Disord; 2016 Dec; 31(12):1883-1890. PubMed ID: 27709663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
    Camporesi E; Lashley T; Gobom J; Lantero-Rodriguez J; Hansson O; Zetterberg H; Blennow K; Becker B
    Acta Neuropathol Commun; 2021 Feb; 9(1):19. PubMed ID: 33522967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans.
    Conway OJ; Carrasquillo MM; Wang X; Bredenberg JM; Reddy JS; Strickland SL; Younkin CS; Burgess JD; Allen M; Lincoln SJ; Nguyen T; Malphrus KG; Soto AI; Walton RL; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Cheshire WP; van Gerpen JA; Uitti RJ; Wszolek ZK; Ross OA; Dickson DW; Graff-Radford NR; Ertekin-Taner N
    Mol Neurodegener; 2018 Oct; 13(1):53. PubMed ID: 30326945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.
    Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH
    Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
    Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI
    Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Passamonti L; Rodríguez PV; Hong YT; Allinson KSJ; Bevan-Jones WR; Williamson D; Jones PS; Arnold R; Borchert RJ; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Neurology; 2018 May; 90(22):e1989-e1996. PubMed ID: 29703774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial tRNA methylation in Alzheimer's disease and progressive supranuclear palsy.
    Silzer TK; Pathak GA; Phillips NR
    BMC Med Genomics; 2020 May; 13(1):71. PubMed ID: 32429992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.